Education
- 2006: Medicine and Surgery (110/110 cum laude) / Vita-Salute San Raffaele University, Italy
- 2012: Neurology Residency (70/70 cum laude) / Vita-Salute San Raffaele University, Italy
- 2016: PhD in International Program of Molecular Medicine – Experimental Neurology / Vita-Salute San Raffaele University, Italy
Awards and Honors
- 2022: Young Physician-Scientist Award / The American Society for Clinical Investigation / US
- 2021: Rita-Levi Montalcini Prize / Italian MS Society (FISM/AISM) / Italy
- 2018: NIH Fellows Award for Research Excellence / NIH / US
- 2016: Award for 2016 Best Paper with IF between 10 and 20 / Italian Society of Neurology / Italy
- 2009: Award for best poster / Italian Society of Neurology / Italy
- Single-cell genomics and multi-omics approaches to study neuroinflammatory and neurodegenerative disorders;
- Human induced pluripotent stem cell-derived modelling of neuroinflammatory disorders;
- Pathobiological understanding and radiological visualization of chronic inflammation in multiple sclerosis lesions and in the meningeal compartment;
- Design of MRI-based clinical trials aimed at preventing or limiting chronic inflammation in multiple sclerosis.
- Absinta M, Sati P, Schindler M, Leibovitch E, Ohayon J, Wu T, Meani A, Filippi M, Jacobson S, Cortese I, Reich DS. Poor outcome in MS lesions with persistent 7-tesla phase rim. J Clin Invest 2016
- Absinta M, Sati P, Masuzzo F, Nair G, Sethi V, Kolb H, Ohajon J, Wu T, Cortese I, Reich DS.Chronic active multiple sclerosis lesions are associated with disability in vivo. JAMA Neurol. 2019
- Absinta M, Maric D, Gharagozloo M, Garton T, Smith MD, Jin J, Fitzgerald KC, Song A, Liu P, Lin JP, Wu T, Johnson KR, McGavern DB, Schafer DP, Calabresi PA, Reich DS. A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis. Nature 2021
- Maggi P, Bulcke CV, Pedrini E, Bugli C, Sellimi A, Wynen M, Stölting A, Mullins WA, Kalaitzidis G, Lolli V, Perrotta G, El Sankari S, Duprez T, Li X, Calabresi PA, van Pesch V, Reich DS, Absinta M.B cell depletion therapy does not resolve chronic active multiple sclerosis lesions. Lancet eBioMedicine 2023
- [5] Fagiani F, Pedrini E, Taverna S, Brambilla, Murtaj V, Podini P, Ruffini F, Butti E, Braccia C, Andolfo A, Magliozzi R, Smirnova L, Kuhlmann T, Quattrini A, Calabresi PA, Reich DS, Martino G, Panina-Bordignon P, Absinta M. A glia-enriched stem-cell 3D model of the human brain mimics the glial-immune neurodegenerative phenotypes of multiple sclerosis. Cell Rep Med 2024